WuXi agrees to Charles River's $1.6 billion bid
April 26, 2010 at 02:48 AM EDT
The Shanghai provider of outsourced drug-research services agrees to be acquired for $21.25 a share, or $1.6 billion, of cash and stock by Charles River Laboratories.
